Nayak R, Orellana D
Immunol Rev. 2024; 325(1):107-130.
PMID: 38864582
PMC: 11338731.
DOI: 10.1111/imr.13358.
Cooper I, Schnaider-Beeri M, Fridkin M, Shechter Y
Pharmaceutics. 2022; 14(1).
PMID: 35056966
PMC: 8778984.
DOI: 10.3390/pharmaceutics14010071.
Thomas T, Joice M, Sumit M, Silpe J, Kotlyar A, Bharathi S
Curr Pharm Des. 2013; 19(37):6594-605.
PMID: 23621534
PMC: 3859140.
DOI: 10.2174/1381612811319370004.
Thomas T, Huang B, Choi S, Silpe J, Kotlyar A, Desai A
Mol Pharm. 2012; 9(9):2669-2676.
PMID: 22827500
PMC: 4457335.
DOI: 10.1021/mp3002232.
Gokhale V, Kulkarni V
J Comput Aided Mol Des. 2000; 14(5):495-506.
PMID: 10896321
DOI: 10.1023/a:1008189724803.
Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae.
Adrian P, Klugman K
Antimicrob Agents Chemother. 1997; 41(11):2406-13.
PMID: 9371341
PMC: 164136.
DOI: 10.1128/AAC.41.11.2406.
A molecular model of the folate binding site of Pneumocystis carinii dihydrofolate reductase.
Southerland W
J Comput Aided Mol Des. 1994; 8(2):113-22.
PMID: 8064329
DOI: 10.1007/BF00119862.
Flexibases: a way to enhance the use of molecular docking methods.
Kearsley S, Underwood D, Sheridan R, Miller M
J Comput Aided Mol Des. 1994; 8(5):565-82.
PMID: 7876901
DOI: 10.1007/BF00123666.
The effects of modification with N-bromosuccinimide on the binding of ligands to dihydrofolate reductase.
Thomson J, Roberts G, BURGEN A
Biochem J. 1980; 187(2):501-6.
PMID: 7396859
PMC: 1161816.
DOI: 10.1042/bj1870501.
Crystallographic and molecular-orbital studies on the geometry of antifolate drugs.
HUNT W, Schwalbe C, Bird K, Mallinson P
Biochem J. 1980; 187(2):533-6.
PMID: 6893149
PMC: 1161822.
DOI: 10.1042/bj1870533.
The kinetic mechanism of the major form of ox kidney aldehyde reductase with D-glucuronic acid.
Daly A, Mantle T
Biochem J. 1982; 205(2):381-8.
PMID: 6814425
PMC: 1158491.
DOI: 10.1042/bj2050381.
Computer simulation of the dynamics of hydrated protein crystals and its comparison with x-ray data.
van Gunsteren W, Berendsen H, Hermans J, Hol W, Postma J
Proc Natl Acad Sci U S A. 1983; 80(14):4315-9.
PMID: 6576339
PMC: 384028.
DOI: 10.1073/pnas.80.14.4315.
19F-n.m.r. studies of 3',5'-difluoromethotrexate binding to Lactobacillus casei dihydrofolate reductase. Molecular motion and coenzyme-induced conformational changes.
Clore G, Gronenborn A, Birdsall B, Feeney J, Roberts G
Biochem J. 1984; 217(3):659-66.
PMID: 6424648
PMC: 1153266.
DOI: 10.1042/bj2170659.
A 1H n.m.r. study of the role of the glutamate moiety in the binding of methotrexate to Lactobacillus casei dihydrofolate reductase.
Antonjuk D, Birdsall B, Cheung H, Clore G, Feeney J, Gronenborn A
Br J Pharmacol. 1984; 81(2):309-15.
PMID: 6423020
PMC: 1986890.
DOI: 10.1111/j.1476-5381.1984.tb10080.x.
The nucleotide sequence of the trimethoprim-resistant dihydrofolate reductase gene harbored by Tn7.
Fling M, Richards C
Nucleic Acids Res. 1983; 11(15):5147-58.
PMID: 6308574
PMC: 326243.
DOI: 10.1093/nar/11.15.5147.
Structure of a bacterial enzyme regulated by phosphorylation, isocitrate dehydrogenase.
Hurley J, Thorsness P, Ramalingam V, Helmers N, Koshland Jr D, Stroud R
Proc Natl Acad Sci U S A. 1989; 86(22):8635-9.
PMID: 2682654
PMC: 298342.
DOI: 10.1073/pnas.86.22.8635.
Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene.
Edman J, Edman U, Cao M, Lundgren B, Kovacs J, Santi D
Proc Natl Acad Sci U S A. 1989; 86(22):8625-9.
PMID: 2682653
PMC: 298340.
DOI: 10.1073/pnas.86.22.8625.
Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
Peterson D, Milhous W, Wellems T
Proc Natl Acad Sci U S A. 1990; 87(8):3018-22.
PMID: 2183222
PMC: 53825.
DOI: 10.1073/pnas.87.8.3018.
